Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOTILLA: Encorafenib/Binimetinib Continuation Study
NCT05203172Phase 4Recruiting
- Sponsor
- Pfizer
- Start
- Jul 2022
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 4 trial of encorafenib, binimetinib in solid tumor, sponsored by Pfizer. Started Jul 2022; status: recruiting.
02
Drugs
encorafenibbinimetinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05203172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05203172.